Clonidine has a vast array of uses including anxiety, ADHD, hypertension, withdrawal (opitates, alcohol and smoking), migraines, menopausal flushing, diarrhoea and finally pain. It causes the classic triad of drowsiness, miosis and bradycardia in overdose.
Centrally acting alpha 2 adrenergic agonist. It act as a sympathoplegic agent and also increases endothelial nitric oxide levels and decreases renin activity.
- Rapid absorption
- Peak serum concentration 1 – 3 hours
- Large volume of distribution 3 – 6 L/kg
- Metabolised by the live and exerted by the urine (although 50% is excreted unchanged)
- Half life 6 – 24 hours
- CNS depression: Intubation and ventilation is usually only required in large overdoses.
- 20ml/kg crystalloid bolus
- Is usually well tolerated and adjunctive therapy should only be considered if the patient is symptomatic with hypotension
- Atropine 0.01 – 0.03 mg/kg IV (usually 600 microgram boluses to a maximum of 1.8 mg)
- Isoprenaline 1 – 10 micrograms/min IV infusion (0.05-1.0 microgram/kg/min in children)
- Adrenaline infusion: 0.15mg/kg in 50ml D5W at 1-10ml/hr (0.05 – 0.5 mcg/kg/min)
- Clinical effects are not entirely dose related. As little as 20 micrograms/kg can cause significant CNS depression in some while higher doses are tolerated well in others.
- Onset of symptoms is usually within 2 hours and definitely by 6.
- The onset of toxicity can be rapid
- Children: 2 tablets is potentially lethal
- >10 micrograms/kg: bradycardia and hypotension
- >20 micrograms/kg: respiratory depression and apnoea
- Clinical effects:
- Lethargy, miosis, slurred speech and ataxia.
- Classically the patient will be deep asleep but can be roused, only to quickly fall back to sleep again
- HR as low as 30 can be common
- Hypotension is less common
- Respiratory depression and apnoea are rare
- Symptoms usually resolve within 24 hours
- Hypotension normally responds to IV fluids
- If intubated see FASTHUGSINBED for further supportive care.
- Screening: 12 lead ECG, BSL, Paracetamol level
- Serial ECGs
- Contraindicated due to the risk of CNS depression
- Not clinical useful
- Naloxone – gives transient improvement in GCS and respiratory rate, however if it is required intubation is recommended as this is more reliable than repeated doses of naloxone.
- Patients who are asymptomatic and have a normal ECG at 6 hours are medically cleared (not for discharge at night)
- Patients with significant features of toxicity and CNS depression require HDU/ICU level care
References and Additional Resources
- Erickson SJ, Duncan A. Clonidine poisoning-an emerging problem: epidemiology, clinical features, management and preventative strategies. Journal of Paediatrics & Child Health 1998; 34(3):280-282.
- Fiser DH, Moss MM, Walker W. Critical care for clonidine poisoning in toddlers. Critical Care Medicine 1990; 18(10):1124-1128.
- Murray L et al. Toxicology Handbook 3rd Edition. Elsevier Australia 2015. ISBN 9780729542241
- Seger DL. Clonidine toxicity revisited. Journal of Toxicology Clinical Toxicology 2002; 40:145-155.
DRUGS and TOXICANTS
Dr Neil Long BMBS FACEM FRCEM FRCPC. Emergency Physician at Kelowna hospital, British Columbia. Loves the misery of alpine climbing and working in austere environments (namely tertiary trauma centres). Supporter of FOAMed, lifelong education and trying to find that elusive peak performance.